RCKT RCKT Try to get out of the wedge
IF it finds strength and volumes TP 28, otherwise it continues the descent
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.75 USD
−245.59 M USD
0.00 USD
96.86 M
About Rocket Pharmaceuticals, Inc.
Sector
Industry
CEO
Gaurav D. Shah
Website
Headquarters
Cranbury
Founded
1999
FIGI
BBG000WG3567
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
The Wash and Rinse To See True Support/ResistanceTrue support and resistance is found in the meat of the move, not at the extreme highs and lows. To find it, Simply draw a zone or box and look for the place that price touches the most, and then pay attention to what happens afterward.
In this lesson, I set up a trade plan and show how a Wash and
Possible Bear flagConsidering the prevailing channel, a possible short rally is imminent, which will be followed by an additional decline in price. Scalpers can enter three cents above today high for few days of rally and exit at any sign of a pullback.
A short would be appropriate at the top of the bear flag for on
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RCKT is 11.68 USD — it has increased by 2.19% in the past 24 hours. Watch Rocket Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rocket Pharmaceuticals, Inc. stocks are traded under the ticker RCKT.
RCKT stock has fallen by −0.26% compared to the previous week, the month change is a −8.18% fall, over the last year Rocket Pharmaceuticals, Inc. has showed a −59.93% decrease.
We've gathered analysts' opinions on Rocket Pharmaceuticals, Inc. future price: according to them, RCKT price has a max estimate of 65.00 USD and a min estimate of 29.00 USD. Watch RCKT chart and read a more detailed Rocket Pharmaceuticals, Inc. stock forecast: see what analysts think of Rocket Pharmaceuticals, Inc. and suggest that you do with its stocks.
RCKT reached its all-time high on Jul 24, 2015 with the price of 77.80 USD, and its all-time low was 3.40 USD and was reached on Jul 10, 2017. View more price dynamics on RCKT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
RCKT stock is 4.31% volatile and has beta coefficient of 1.46. Track Rocket Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Rocket Pharmaceuticals, Inc. there?
Today Rocket Pharmaceuticals, Inc. has the market capitalization of 1.24 B, it has decreased by −4.11% over the last week.
Yes, you can track Rocket Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Rocket Pharmaceuticals, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
RCKT earnings for the last quarter are −0.71 USD per share, whereas the estimation was −0.75 USD resulting in a 5.37% surprise. The estimated earnings for the next quarter are −0.72 USD per share. See more details about Rocket Pharmaceuticals, Inc. earnings.
Rocket Pharmaceuticals, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 0.00 USD. In the next quarter, revenue is expected to reach 28.45 K USD.
RCKT net income for the last quarter is −66.72 M USD, while the quarter before that showed −69.65 M USD of net income which accounts for 4.20% change. Track more Rocket Pharmaceuticals, Inc. financial stats to get the full picture.
No, RCKT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 268.00 employees. See our rating of the largest employees — is Rocket Pharmaceuticals, Inc. on this list?
Like other stocks, RCKT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rocket Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rocket Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rocket Pharmaceuticals, Inc. stock shows the strong sell signal. See more of Rocket Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.